| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4261455 | Transplantation Proceedings | 2006 | 4 Pages |
Abstract
The combination of α-IFN plus ribavirin induced a sustained virologic response in 20% of liver transplant recipients with recurrent HCV, but intolerance of the therapy prompted its discontinuation or a dosage reduction in a large proportion of patients. However, we have observed a long-term efficacy of the antiviral therapy in the sustained responders.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
P. Burra, S. Targhetta, S. Pevere, S. Boninsegna, M. Guido, D. Canova, A. Brolese, A. Masier, C. D'Aloiso, G. Germani, S. Tomat, S. Fagiuoli,